Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07186296 · ClinicalTrials.gov registry record

EXoPERT EMERALD Clinical Study

A clinical trial of Breast Cancer and Lung Cancer, sponsored by EXoPERT.

Recruiting
Registry status
1,400
Enrollment target
9
Study locations

NCT07186296 is a study of Breast Cancer and Lung Cancer that is actively recruiting participants, run by EXoPERT. The registered enrollment target is 1,400 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (50% lower). The trial reports 9 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07186296, a study of Breast Cancer and Lung Cancer, is actively recruiting participants, sponsored by EXoPERT.

RECRUITING
Registry status
1,400 participants
Enrollment target
9
Study locations

Study Summary

Invitro diagnostic test for multiple cancer diagnosis for patients with early-stage cancers by analyzing surface-enhanced Ramen spectroscopy (SERS) profiles of extracellular vesicles (EV) using artificial intelligence.

Conditions Studied

Breast Cancer Lung Cancer Ovarian Cancer Pancreatic Cancer Colon Cancer

Interventions

  • DIAGNOSTIC_TEST EXoPred

Study Locations (9)

New York

  • Albany Stratton VA Medical Center - Albany
  • Bronx Veterans Medical Research Foundation - The Bronx
  • VA Hudson Valley Healthcare System - Wappingers Falls

California

  • Tibor Rubin VA Medical Center - Long Beach
  • City of Hope Duarte Cancer Center - Los Angeles

Kentucky

  • Lexington VA Healthcare System - Lexington
  • KCTL - Louisville

Hawaii

  • University of Hawaii Cancer Center - Honolulu

Maryland

  • John Hopkins University - Baltimore

Trial Details

FieldValue
Enrollment Target 1,400 participants
Start Date 2025-05-09
Est. Completion 2026-06-30

Sponsor

EXoPERT

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07186296

The ClinicalTrials.gov registry entry for NCT07186296 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (50% lower). The listed sponsor is EXoPERT, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which EXoPred is the first listed.

NCT07186296 reports 9 study locations spanning 5 distinct geographic areas - top geographies include New York, California, Kentucky.

Frequently Asked Questions

What is clinical trial NCT07186296 about?

NCT07186296 is a clinical study titled "EXoPERT EMERALD Clinical Study". Invitro diagnostic test for multiple cancer diagnosis for patients with early-stage cancers by analyzing surface-enhanced Ramen spectroscopy (SERS) profiles of extracellular vesicles (EV) using artificial intelligence.

What is the current status of trial NCT07186296?

This trial is currently recruiting. The enrollment target is 1,400 participants. The study started on 2025-05-09. Estimated completion is 2026-06-30.

What conditions does trial NCT07186296 study?

This clinical trial studies the following conditions: Breast Cancer, Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Colon Cancer.

What interventions are being tested in trial NCT07186296?

The interventions under investigation include: EXoPred (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT07186296?

This trial is sponsored by EXoPERT, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07186296 being conducted?

This trial has 9 study locations across California, Hawaii, Kentucky, Maryland, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Breast Cancer

All registered trials for this condition

Lung Cancer

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.